G2GBIO Inc. (KOSDAQ:456160)
South Korea · Delayed Price · Currency is KRW 53,700
-2,700 (-4.79%)
At close: Jun 2, 2026
G2GBIO Market Cap
G2GBIO has a market cap or net worth of 888.49 billion as of June 3, 2026.
Market Cap
888.49B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
53,700.00
Market Cap Chart
Since August 14, 2025, G2GBIO's market cap has increased from 503.30B to 888.49B, an increase of 76.53%. That is a compound annual growth rate of 103.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 888.49B | -19.24% |
| Dec 30, 2025 | 1.10T | 118.59% |
| Aug 14, 2025 | 503.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 390.41B |
| Samyang Biopharm | 385.92B |
| HEM Pharma | 336.56B |
| NOVAREX | 252.70B |
| CellBion | 248.93B |
| DAE HWA Pharmaceutical | 204.94B |
| Vivozon Pharmaceutical | 170.27B |
| High Tech Pharm | 161.20B |